Stephen Kanes, Chief Medical Officer at Sage Therapeutics, Inc. (SAGE), sold 12,000 shares at $53.12 ($637K) on 2015-08-31, disclosed to the SEC on 2015-09-01.
Scheduled sale ($637k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SAGE | SELL | 2016-04-21 | $798K | — | Filing → |
| SAGE | SELL | 2015-09-29 | $279K | — | Filing → |
| SAGE | SELL | 2015-07-29 | $347K | — | Filing → |